Journal of Microbiology and Biotechnology

  • 제30권4호
  • /
  • Pages.477-481
  • /
  • 2020
  • /
  • 1017-7825(pISSN)
  • /
  • 1738-8872(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells

  • Akter, Shahina (Department of Food Science and Biotechnology, College of BioNano Technology, Gachon University) ;
  • Park, Jong-Hyun (Department of Food Science and Biotechnology, College of BioNano Technology, Gachon University) ;
  • Jung, Hoo Kil (Department of Food Science and Biotechnology, College of BioNano Technology, Gachon University)
  • 투고 : 2019.11.11
  • 심사 : 2020.01.02
  • 발행 : 2020.04.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Viability plays an important role in the beneficial microbes (probiotics) to produce health benefits. However, this idea has been changed after the invention of the term "paraprobiotics," indicating that non-viable microbes could produce health benefits similar to those produced by live probiotics. Occasionally, it might be dangerous to administer live probiotics to people with weak immunity. In such cases, ingestion of paraprobiotics could be a potential alternative. The definition of paraprobiotics refers to the use of inactivated (non-viable) microbial cells or cell fractions to provide health benefits to the consumer. Paraprobiotics have attracted much attention because of their long shelf life, safety, and beneficial effects, such as modulation of immunity, modification of biological responses, reduction of cholesterol, anti-inflammatory, and antiproliferative properties. These features indicate that paraprobiotics may play a vital role in improving the health of the consumer by enhancing particular physiological functions, even though the exact underlying mechanisms have not yet been completely elucidated. In this mini-review, we briefly discuss the historical backgrounds of paraprobiotics and evidence of their health-promoting effects, prophylactic, and therapeutic properties.

키워드

참고문헌

  1. Taverniti V, Guglielmetti S. 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: Proposal of paraprobiotic concept). Genes Nutr. 6: 261-274. https://doi.org/10.1007/s12263-011-0218-x
  2. de Almada CN, Almada CN, Martinez CRR, SantAna AS. 2016. Paraprobiotics: evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends Food Sci. Technol. 58: 96-114. https://doi.org/10.1016/j.tifs.2016.09.011
  3. Aguilar-Toala JE, Garcia-Varela R, Garcia HS, Mata-Haro V, Gonzalez-Cordova AF, Vallejo-Cordoba B, et al. 2018. Postbiotics: An evolving term within the functional foods field. Trends. Food Sci. Technol. 75: 105-114. https://doi.org/10.1016/j.tifs.2018.03.009
  4. Adams CA. 2010. The probiotic paradox: Live and dead cells are biological response modifiers. Nutr. Res. Rev. 23: 37-46. https://doi.org/10.1017/S0954422410000090
  5. Shimosato T, Kitazawa H. 2013. Immunogenics: Immunostimulatory oligodeoxynucleotides from probiotics. In: Kitazawa H, Villena J, Alvarez S. Eds., Probiotics: Immunobiotics and Immunogenics, CRC Press, Boca Raton. pp. 336-350. http://dx.doi.org/10.1201/b15532-14.
  6. Shigwedha N, Sichel L, Jia L, Zhang L. 2014a. Probiotical cell fragments (PCFs) as novel nutraceutical ingredients. J. Biosci. Med. 2: 43-55.
  7. Shigwedha N, Zhang L, Sichel L, Jia L, Gong P, Liu W, et al. 2014b. More than a few LAB alleviate common allergies: Impact of paraprobiotics in comparison to probiotical live cells. J. Biosci. Med. 2: 56-64. https://doi.org/10.4236/jbm.2014.23008
  8. Sarkar S. 2016. Efficacy of dead probiotic cells. Int. J. Food Sci. Nutr. Diet. 5(2e): 1.
  9. Bajpai VK, Chandra V, Kim NH, Rai R, Kumar P, Kim K, et al. 2017. Ghost probiotics with a combined regimen: A novel therapeutic approach against the Zika virus, an emerging world threat. Crit. Rev. Biotechnol. 38: 438-454. https://doi.org/10.1080/07388551.2017.1368445
  10. Thakur BK, Saha P, Banik G, Saha DR, Grover S, Batish VK, et al. 2016. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. Int. Immunopharmacol. 36: 39-50. https://doi.org/10.1016/j.intimp.2016.03.033
  11. Salminen S, Ouwehand A, Benno Y, Lee YK. 1999. Probiotics: How should they be defined? Trends Food Sci. Technol. 10: 107-110. https://doi.org/10.1016/S0924-2244(99)00027-8
  12. Mitsuoka T. 2014. Development of functional foods. Biosci. Microbiota Food Health 33: 117-128. https://doi.org/10.12938/bmfh.2014-003
  13. Middelbos IS, Godoy MR, Fastinger ND, Fahey GC. 2007. A dose-response evaluation of spray-dried yeast cell wall supplementation of diets fed to adult dogs: Effects on nutrient digestibility, immune indices, and fecal microbial populations. J. Anim. Sci. 85: 3022-3032. https://doi.org/10.2527/jas.2007-0079
  14. Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, et al. 2003. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor a-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immunol. 10: 259-266. https://doi.org/10.1128/cdli.10.2.259-266.2003
  15. Salinas I, Meseguer J, Esteban A. 2008. Antiproliferative effects and apoptosis induction by probiotic cytoplasmic extracts in fish cell lines. Vet. Microbiol. 126: 287-294. https://doi.org/10.1016/j.vetmic.2007.07.003
  16. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, et al. 2004. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126: 1358-1373. https://doi.org/10.1053/j.gastro.2004.02.003
  17. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB. 2004. Probiotics inhibit nuclear factor-kappa-B and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127:1474-1487. https://doi.org/10.1053/j.gastro.2004.09.001
  18. Cross ML, Gill HS. 2001. Can immunoregulatory LAB be used as dietary supplements to limit allergies? Int. Arch. Allergy Immunol. 125: 112-119. https://doi.org/10.1159/000053804
  19. Posadas GA, Broadway PR, Thornton JA, Carroll JA, Lawrence A, Corley JR, et al. 2017. Yeast pro- and paraprobiotics have the capability to bind pathogenic bacteria associated with animal disease. Transl. Anim. Sci. 1: 60-68. https://doi.org/10.2527/tas2016.0007
  20. Hopkins PA, Sriskandan S. 2005. Mammalian Toll-like receptors: To immunity and beyond. Clin. Exp. Immunol. 140: 395-407. https://doi.org/10.1111/j.1365-2249.2005.02801.x
  21. Lien E, Ingalls RR. 2002. Toll-like receptors. Crit. Care Med. 30: S1-S11. https://doi.org/10.1097/00003246-200201001-00001
  22. Amrouche T, Boutin Y, Fliss I. 2006. Effects of bifidobacterial cytoplasm peptide and protein fractions on mouse lymphocyte proliferation and cytokine production. Food Agr. Immunol. 17: 29-42. https://doi.org/10.1080/09540100600565895
  23. Shimosato T, Kimura T, Tohno M, Dimitrov II, Katoh S, Ito Y, et al. 2006. Strong immunostimulatory activity of AToligodeoxynucleotide requires a six-base loop with a self-stabilized 5?-C…G-3? stem structure. Cell. Microbiol. 8(3): 485-495.
  24. Erickson KL, Hubbard NE. 2000. Probiotic immunomodulation in health and disease. J. Nutr. 130(2S Suppl): 403S-409S. https://doi.org/10.1093/jn/130.2.403S
  25. Sashihara T, Sueki N, Ikegami S. 2006. An analysis of the effectiveness of heat-killed LAB in alleviating allergic diseases. J. Dairy Sci. 89: 2846-2855. https://doi.org/10.3168/jds.S0022-0302(06)72557-7
  26. Kankaanpaa P, Sutasb Y, Salminena S, Isolaurib E. 2003. Homogenates derived from probiotic bacteria provide down-regulatory signals for peripheral blood mononuclear cells. Food Chem. 83: 269-277. https://doi.org/10.1016/S0308-8146(03)00090-6
  27. Ryu YH, Baik JE, Yang JS, Kang SS, Im J, Yun CH, et al. 2009. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 9: 127-133. https://doi.org/10.1016/j.intimp.2008.10.014
  28. Makino S, Ikegami S, Kano H, Sashihara T, Sugano H, Horiuchi H, et al. 2006. Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J. Dairy Sci. 89: 2873-2881. https://doi.org/10.3168/jds.S0022-0302(06)72560-7
  29. Sasaki E, Suzuki S, Fukui Y, Yajima N. 2015. Cell-bound exopolysaccharides of Lactobacillus brevis KB290 enhance cytotoxic activity of mouse splenocytes. J. Appl. Microbiol. 118: 506-514. https://doi.org/10.1111/jam.12686
  30. Kimoto-Nira H. 2018. New LAB for skin health via oral intake of heat-killed or live cells. Anim. Sci. J. 89: 835-842. https://doi.org/10.1111/asj.13017
  31. Sawada D, Sugawara T, Ishida Y, Aihara K, Aoki Y, Takehara I, et al. 2016. Effect of continuous ingestion of a beverage prepared with Lactobacillus gasseri CP2305 inactivated by heat treatment on the regulation of intestinal function. Food Res. Int. 79: 33-39. https://doi.org/10.1016/j.foodres.2015.11.032
  32. Tanzer JM, Thompson A, Lang C, Cooper B, Hareng L, Gamer A, et al. 2010. Caries inhibition by and safety of Lactobacillus paracasei DSMZ16671. J. Dental Res. 89: 921-926. https://doi.org/10.1177/0022034510369460
  33. Sugawara T, Sawada D, Ishida Y, Aihara K, Aoki Y, Takehara I, et al. 2016. Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and function. Microb. Ecol. Health Dis. 27: 30259-30269.
  34. Serin Y, Andruskiene J. 2017. New perspective for functional component of foods: Paraprobiotics. International Conference - Biomedical and Social Sciences: Education, Research and Innovation 2017. Klaipeda State University of Applied Science Faculty of Health Science. pp. 30-32. 11th of April, Klaipeda.

피인용 문헌

  1. Shotgun metagenomic analysis reveals new insights into bacterial community profiles in tempeh vol.13, 2020, https://doi.org/10.1186/s13104-020-05406-6
  2. Immuno-modulation by heat-killed Lacticaseibacillus paracasei MCC1849 and its application to food products vol.35, 2020, https://doi.org/10.1177/20587384211008291
  3. Paraprobiotics: A New Perspective for Functional Foods and Nutraceuticals vol.13, pp.4, 2021, https://doi.org/10.3390/nu13041225
  4. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges vol.22, pp.9, 2021, https://doi.org/10.3390/ijms22094942
  5. Probiotics in the dairy industry-Advances and opportunities vol.20, pp.4, 2020, https://doi.org/10.1111/1541-4337.12755
  6. The Effect of Probiotics on Quality of Life, Depression and Anxiety in Patients with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis vol.10, pp.16, 2020, https://doi.org/10.3390/jcm10163497
  7. Wheat-durum pasta added of inactivated Bifidobacterium animalis decreases glucose and total cholesterol levels and modulates gut microbiota in healthy rats vol.72, pp.6, 2020, https://doi.org/10.1080/09637486.2021.1877261
  8. Heat‐killed Mycolicibacterium aurum Aogashima: An environmental nonpathogenic actinobacteria under development as a safe novel food ingredient vol.9, pp.9, 2020, https://doi.org/10.1002/fsn3.2413
  9. Effects of Feeding a Hypoallergenic Diet with a Nutraceutical on Fecal Dysbiosis Index and Clinical Manifestations of Canine Atopic Dermatitis vol.11, pp.10, 2021, https://doi.org/10.3390/ani11102985
  10. Effects of Heat-Killed Lactococcus lactis Strain Plasma on Skin Homeostasis-Related Genes and the Skin Microbiome among Healthy Adults: A Randomized Controlled Double-Blind Study vol.9, pp.10, 2021, https://doi.org/10.3390/microorganisms9102029
  11. Paraprobiotics obtained by six different inactivation processes: impacts on the biochemical parameters and intestinal microbiota of Wistar male rats vol.72, pp.8, 2020, https://doi.org/10.1080/09637486.2021.1906211
  12. Obtaining paraprobiotics from Lactobacilus acidophilus, Lacticaseibacillus casei and Bifidobacterium animalis using six inactivation methods: Impacts on the cultivability, integrity, physiology, and m vol.87, 2020, https://doi.org/10.1016/j.jff.2021.104826
  13. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD vol.11, pp.12, 2021, https://doi.org/10.3390/biom11121903